d-Neomenthol

CAS No. 2216-52-6

d-Neomenthol( (1S2S5R)-2-Isopropyl-5-Methylcyclohexanol | (+)-Neomenthol )

Catalog No. M21234 CAS No. 2216-52-6

d-Neomenthol is a natural product.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 33 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    d-Neomenthol
  • Note
    Research use only, not for human use.
  • Brief Description
    d-Neomenthol is a natural product.
  • Description
    d-Neomenthol is a natural product.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (1S2S5R)-2-Isopropyl-5-Methylcyclohexanol | (+)-Neomenthol
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2216-52-6
  • Formula Weight
    156.26
  • Molecular Formula
    C10H20O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (639.92 mM)
  • SMILES
    CC(C)[C@H](CC[C@@H](C)C1)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Williams R T . Studies in detoxication: The biological reduction of l-menthone to d-neomenthol and of d-isomenthone to d-isomenthol in the rabbit. The conjugation of d-neomenthol with glucuronic acid.[J]. Biochemical Journal 1940 34(5):690.
molnova catalog
related products
  • Toralactone-9-O-trig...

    Toralactone-9-O-triglucoside

  • AMPC

    AMPC is a TFF3 inhibitor with antitumor activity and inhibits tumor growth in vivo. AMPC inhibits cell proliferation and survival in TFF3-positive CMS4 colorectal cancer cells and can be used to study colorectal cancer.

  • L524-0366

    L524-0366 is a TWEAK-Fn14 signaling cascade inhibitor.L524-0366 mitigated maladaptive remodeling with TAC. TWEAK induced secretion of the pro-inflammatory chemokine, monocyte chemoattractant protein 1 from WT but not Fn14-/-?fibroblasts in vitro, in part through activation of non-canonical NF-κB signaling.